Pro Share Advisors LLC Crispr Therapeutics Ag Transaction History
Pro Share Advisors LLC
- $39.7 Billion
- Q3 2024
A detailed history of Pro Share Advisors LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Pro Share Advisors LLC holds 5,358 shares of CRSP stock, worth $216,945. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,358
Previous 5,568
3.77%
Holding current value
$216,945
Previous $300,000
16.33%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding CRSP
# of Institutions
485Shares Held
58.9MCall Options Held
1.09MPut Options Held
1.9M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$363 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA7.93MShares$321 Million0.07% of portfolio
-
State Street Corp Boston, MA2.99MShares$121 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$120 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$112 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.16B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....